Stem Cell market research reports by DelveInsight

• CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 7,500

  CAR T-Cell Therapy for Acute Lymphoblastic Leukemia (ALL) - Market Insight, Epidemiology And Market Forecast - 2032 Key Highlights The main treatment options for ALL include chemotherapy, targeted therapy, immunotherapy, surgery, radiation therapy, and stem cell transplant. In the last few years, im ... Read More

• Organoids - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Organoids - Market Insights, Competitive Landscape, and Market Forecast - 2030 Organoids Market By Product Type (Pancreas, Intestine, Lung, Liver, Neural, And Others), Source (Pluripotent Stem Cells (Hipscs), And Adult Stem Cells (Ascs), Application (Disease Pathology, Regenerative Medicine, Drug Te ... Read More

• Viral Vector Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030

  Jul 01, 2024  |  Published by: DelveInsight  |  USD 3,750

  Viral Vector Manufacturing - Market Insights, Competitive Landscape, and Market Forecast - 2030 Viral Vector Manufacturing Market By Type (Adenoviral Vectors, Adeno-Associated Viral (AAV) Vectors, Lentiviral Vectors, And Others), By Application (Gene Therapy, Cell Therapy, And Vaccines), By End-User ... Read More

• CAR T-Cell Therapy for Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  CAR T-Cell Therapy for Multiple Myeloma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""CAR T-Cell Therapy for Multiple Myeloma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the CAR T-Cell Therapy for Multiple M ... Read More

• Limbal Stem Cells Deficiency (lsd) – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Limbal Stem Cells Deficiency (lsd) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Limbal Stem Cells Deficiency (lsd) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Limbal Stem Cells Deficiency (lsd), histori ... Read More

• Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Allogeneic T-cell therapy for autoimmune diseases – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Allogeneic T-cell therapy for autoimmune diseases – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Allogeneic T- ... Read More

• CAR T-cell Therapy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  CAR T-cell Therapy - Pipeline Insight, 2024 DelveInsight’s, “CAR T-cell Therapy - Pipeline Insight, 2024” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in CAR T-cell Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclin ... Read More

• Neo Antigen T-cell Therapy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Neo Antigen T-cell Therapy - Pipeline Insight, 2024 Neo Antigen T-cell Therapy Overview ""Neo Antigen T-cell Therapy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Neo Antigen T-cell Therapy mark ... Read More

• CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Multiple Myeloma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Multiple Myeloma pipeline landscape. It cover ... Read More

• Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Pipeline Insight, 2024 Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) Overview ""Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present ... Read More

• Allogenic Cell Therapies - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Allogenic Cell Therapies - Pipeline Insight, 2024 Allogenic Cell Therapies Overview ""Allogenic Cell Therapies Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allogenic Cell Therapies market. A de ... Read More

• CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Acute Lymphoblastic Leukemia - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Acute Lymphoblastic L ... Read More

• Allogenic iNKT Cell Therapy - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Allogenic iNKT Cell Therapy - Pipeline Insight, 2024 Allogenic iNKT Cell Therapy Overview ""Allogenic iNKT Cell Therapy Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Allogenic iNKT Cell Therapy ... Read More

• CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  CAR T-Cell Therapy for Non-Hodgkin’s lymphoma– - Pipeline Insight, 2024 DelveInsight’s, “CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma - Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in CAR T-Cell Therapy for Non-Hodgkin’s Lymphoma pipeline ... Read More

• Apoptosis Inhibitor - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Apoptosis Inhibitor - Pipeline Insight, 2024 “Apoptosis Inhibitor - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Apoptosis Inhibitor development. The report provides detailed coverag ... Read More

• CAR-T Therapy- Pipeline Insight, 2023

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 5,000

  CAR-T Therapy- Pipeline Insight, 2023 DelveInsight’s, “CAR-T Therapy- Pipeline Insight, 2023” report provides comprehensive insights about 200+ companies and 252+ pipeline drugs in CAR-T Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage produc ... Read More

• CAR T - Cell Therapy- Competitive landscape, 2023

  Apr 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  CAR T - Cell Therapy- Competitive landscape, 2023 DelveInsight’s, “CAR T - Cell Therapy- Competitive landscape, 2023,” report provides comprehensive insights about 250+ companies and 500+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, stag ... Read More

• Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Angioimmunoblastic T-cell lymphoma - Pipeline Insight, 2023 DelveInsight’s, “Angioimmunoblastic T cell Lymphoma – Pipeline Insight, 2023,” report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Angioimmunoblastic T cell Lymphoma pipeline landscape. It covers the pipelin ... Read More

• CAR T - Cell Therapy - Competitive Landscape, 2022

  Oct 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  CAR T - Cell Therapy - Competitive Landscape, 2022 DelveInsight’s, “CAR T - Cell Therapy - Competitive landscape, 2022,” report provides comprehensive insights about 193+ companies and 450+ drugs in CAR T - Cell Therapy Competitive landscape. It covers the therapeutics assessment by product type, st ... Read More

• Hematopoietic Stem Cell Transplantation - Market Insight, Epidemiology And Market Forecast - 2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Hematopoietic Stem Cell Transplantation - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s ‘Hematopoietic Stem Cell Transplantation (HSCT) - Market Insights, Epidemiology, and Market Forecast–2032’ report delivers an in-depth understanding of HSCT historical and forecasted epid ... Read More

• Stem Cell - Market Insights, Competitive Landscape and Market Forecast–2027

  Jul 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Stem Cell - Market Insights, Competitive Landscape and Market Forecast–2027 Stem Cell Market By Product Type (Adult Stem Cell, Human Embryonic Cell, Pluripotent Stem Cell, Others), By Application (Neurological Disorders, Orthopedic Treatments, Oncology Disorders, Injuries And Wounds, Cardiovascular ... Read More

• Natural Killer (NK) cell therapy - Pipeline Insight, 2022

  Mar 01, 2022  |  Published by: DelveInsight  |  USD 5,000

  DelveInsight’s, “ Natural Killer (NK) cell therapy – Pipeline Insight, 2022 ,” report provides comprehensive insights about 100+ companies and 185+ pipeline drugs in Natural Killer (NK) cell therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pr ... Read More

• CAR T - Pipeline Insight, 2022

  Feb 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  DelveInsight’s, “ CAR-T – Pipeline Insight, 2022 ,” report provides comprehensive insights about 120+ companies and 460+ pipeline drugs in CAR-T pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by ... Read More

• Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Epidemiology Forecast - 2032

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,950

  DelveInsight's "" Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) - Epidemiology Forecast to 2032 "" report delivers an in-depth understanding of the disease, historical and forecasted Allogeneic Hematopoietic Stem Cell Transplant (Allo-HSCT) epidemiology in the 7MM, i.e., the United State ... Read More

• CAR T-cell Therapy - Pipeline Insight, 2022

  Jan 01, 2022  |  Published by: DelveInsight  |  USD 3,000

  “ CAR T-cell Therapy - Pipeline Insight, 2022 ” report provides comprehensive insights about 300+ companies and 300+ pipeline drugs in CAR T-cell Therapy pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics asses ... Read More

< prev 1 2 next >